Try our Advanced Search for more refined results
- January 12, 2023 Testing The Doctrine of Equivalents' Chemical Patent Context
- January 03, 2023 Fed. Circ. Backs Decision Clearing Pfizer On Heart Drug IP
- December 06, 2022 Fed. Circ. Wary Of Reviving Gilead's Lexiscan IP Suit
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS